Xin Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xin Wu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Hong-Bing Shu
Department of Infectious Diseases, Medical Research Institute, Taikang Center for Life and Medical Sciences, State Key Laboratory for Virology and Biosafety, Zhongnan Hospital of Wuhan University, Wuhan University
3 shared publications Jin-Ke Yang
Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences Gansu Province Research Center for Basic Disciplines of Pathogen Biology Lanzhou 730046
3 shared publications- Tian Xia
State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
3 shared publications Yuan-Pan Hou
Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences Gansu Province Research Center for Basic Disciplines of Pathogen Biology Lanzhou 730046
3 shared publicationsYue Wang
State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Lanzhou 730000
3 shared publications- Mi Li
Department of Infectious Diseases, Medical Research Institute, Taikang Center for Life and Medical Sciences, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (11)
The lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression
Lumpy skin disease (LSD) is a severe transboundary disease of cattle caused by lumpy skin disease virus (LSDV), which is highly transmissible and responsible for substantial economic losses worldwide. Although cellular immune responses are critical for controlling poxvirus infections, the viral strategies used by LSDV to evade cytotoxic T-cell immunity remain poorly understood. In this study, we demonstrate that LSDV infection markedly downregulates major histocompatibility complex class I (MHC-I) surface expression in host cells. Screening of LSDV-encoded proteins identified LSDV003 as a key viral factor responsible for MHC-I downregulation. Mechanistically, LSDV003 interacts with both the MHC-I heavy chain and β2-microglobulin and mediates endoplasmic reticulum (ER) retention of MHC-I via a C-terminal HNEL motif, thereby preventing its transport to the cell surface. Mutational analyses demonstrated that disruption of the HNEL motif impaired the ability of LSDV003 to alter MHC-I localization and surface expression. Furthermore, an LSDV003-deficient virus exhibited a markedly reduced capacity to suppress MHC-I surface expression. Collectively, these findings identify LSDV003 as a viral regulator of MHC-I trafficking and reveal a mechanism by which LSDV modulates host immune recognition. IMPORTANCE: Lumpy skin disease is a highly contagious viral disease of cattle that has spread rapidly across Afro-Eurasia and causes major economic losses. However, the mechanisms used by lumpy skin disease virus to evade host immune defenses remain incompletely understood. In this study, we identify a previously unrecognized lumpy skin disease virus protein, LSDV003, that reduces the surface expression of major histocompatibility complex class I molecules in infected cells. We found that LSDV003 prevents these molecules from leaving the endoplasmic reticulum by using a C-terminal retention motif, thereby altering their normal intracellular trafficking. An LSDV003-deficient virus showed a reduced ability to suppress major histocompatibility complex class I surface expression during infection. These findings reveal an important immune evasion strategy used by lumpy skin disease virus and highlight LSDV003 as a potential target for improved vaccines and antiviral approaches to control this economically important disease.
- 11 November 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (11)
Open AccessThe lumpy skin disease virus protein LSDV003 regulates MHC-I trafficking and surface expression
Lumpy skin disease (LSD) is a severe transboundary disease of cattle caused by lumpy skin disease virus (LSDV), which is highly transmissible and responsible for substantial economic losses worldwide. Although cellular immune responses are critical for controlling poxvirus infections, the viral strategies used by LSDV to evade cytotoxic T-cell immunity remain poorly understood. In this study, we demonstrate that LSDV infection markedly downregulates major histocompatibility complex class I (MHC-I) surface expression in host cells. Screening of LSDV-encoded proteins identified LSDV003 as a key viral factor responsible for MHC-I downregulation. Mechanistically, LSDV003 interacts with both the MHC-I heavy chain and β2-microglobulin and mediates endoplasmic reticulum (ER) retention of MHC-I via a C-terminal HNEL motif, thereby preventing its transport to the cell surface. Mutational analyses demonstrated that disruption of the HNEL motif impaired the ability of LSDV003 to alter MHC-I localization and surface expression. Furthermore, an LSDV003-deficient virus exhibited a markedly reduced capacity to suppress MHC-I surface expression. Collectively, these findings identify LSDV003 as a viral regulator of MHC-I trafficking and reveal a mechanism by which LSDV modulates host immune recognition. IMPORTANCE: Lumpy skin disease is a highly contagious viral disease of cattle that has spread rapidly across Afro-Eurasia and causes major economic losses. However, the mechanisms used by lumpy skin disease virus to evade host immune defenses remain incompletely understood. In this study, we identify a previously unrecognized lumpy skin disease virus protein, LSDV003, that reduces the surface expression of major histocompatibility complex class I molecules in infected cells. We found that LSDV003 prevents these molecules from leaving the endoplasmic reticulum by using a C-terminal retention motif, thereby altering their normal intracellular trafficking. An LSDV003-deficient virus showed a reduced ability to suppress major histocompatibility complex class I surface expression during infection. These findings reveal an important immune evasion strategy used by lumpy skin disease virus and highlight LSDV003 as a potential target for improved vaccines and antiviral approaches to control this economically important disease.
- Open Access
- 14 July 2026
- Published by Oxford University Press (OUP) in Protein & Cell
African swine fever virus MGF_110-3L and MGF_110-4L signal TLR2-mediated lethal inflammation
African swine fever virus (ASFV) is a lethal pathogen that triggers uncontrolled cytokine storms and severe immunopathology. However, the viral factors responsible for systemic inflammation remain unclear. Here, we show that the ASFV-encoded proteins MGF_110-3L and MGF_110-4L are secreted via the conventional ER-Golgi pathway. Single-cell RNA sequencing of porcine PBMCs revealed that MGF_110-3L preferentially activates inflammatory responses in monocytic cells. Mechanistically, both proteins bind Toll-like receptor 2 (TLR2) and signal through TLR2/TLR1 and TLR2/TLR6 heterocomplexes, with the co-receptor CD14 enhancing ligand recognition and signal amplification. These interactions activate MyD88-dependent NF-κB signaling, leading to robust induction of proinflammatory cytokines. ASFV strains lacking either MGF_110-3L or MGF_110-4L cause attenuated cytokine responses in vitro and impaired inflammatory pathology in pigs. Together, these findings establish MGF_110-3L and MGF_110-4L as secreted virulence factors that subvert innate immune recognition and drive lethal inflammation, highlighting their potential as targets for antiviral and vaccine development.
- 14 July 2026
- Published by Oxford University Press (OUP) in Protein & Cell
Open AccessAfrican swine fever virus MGF_110-3L and MGF_110-4L signal TLR2-mediated lethal inflammation
African swine fever virus (ASFV) is a lethal pathogen that triggers uncontrolled cytokine storms and severe immunopathology. However, the viral factors responsible for systemic inflammation remain unclear. Here, we show that the ASFV-encoded proteins MGF_110-3L and MGF_110-4L are secreted via the conventional ER-Golgi pathway. Single-cell RNA sequencing of porcine PBMCs revealed that MGF_110-3L preferentially activates inflammatory responses in monocytic cells. Mechanistically, both proteins bind Toll-like receptor 2 (TLR2) and signal through TLR2/TLR1 and TLR2/TLR6 heterocomplexes, with the co-receptor CD14 enhancing ligand recognition and signal amplification. These interactions activate MyD88-dependent NF-κB signaling, leading to robust induction of proinflammatory cytokines. ASFV strains lacking either MGF_110-3L or MGF_110-4L cause attenuated cytokine responses in vitro and impaired inflammatory pathology in pigs. Together, these findings establish MGF_110-3L and MGF_110-4L as secreted virulence factors that subvert innate immune recognition and drive lethal inflammation, highlighting their potential as targets for antiviral and vaccine development.
- 6 April 2026
- Published by Elsevier in Veterinary Microbiology
- Vol. 317, 111013
African swine fever virus MGF_110-8L promotes host cell autophagy and suppresses interferon signaling by activating the unfolded protein response
- 6 April 2026
- Published by Elsevier in Veterinary Microbiology
- Vol. 317, 111013
African swine fever virus MGF_110-8L promotes host cell autophagy and suppresses interferon signaling by activating the unfolded protein response
- Open Access
- 26 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (4) , 111333
Brucella Omp25 activates the unfolded protein response to promote intracellular proliferation and inflammation
- 26 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (4) , 111333
Open AccessBrucella Omp25 activates the unfolded protein response to promote intracellular proliferation and inflammation
- 16 December 2025
- Published by Elsevier in Current Opinion in Virology
- Vol. 74, 101506
Clinical and mechanistic insights into Brucella and viral co-infection
- 16 December 2025
- Published by Elsevier in Current Opinion in Virology
- Vol. 74, 101506
Clinical and mechanistic insights into Brucella and viral co-infection